Myriad Genetics
MYGN
MYGN
232 hedge funds and large institutions have $3.86B invested in Myriad Genetics in 2015 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 75 increasing their positions, 95 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
21% less repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 95
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
232
Holding in Top 10
3
Calls
$14.2M
Puts
$15.4M
Top Buyers
| 1 | +$86.3M | |
| 2 | +$29.8M | |
| 3 | +$27.2M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$26.3M |
| 5 |
Morgan Stanley
New York
|
+$20.8M |
Top Sellers
| 1 | -$92.7M | |
| 2 | -$60M | |
| 3 | -$44.8M | |
| 4 |
RA
Royce & Associates
New York
|
-$37M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
-$26.1M |